Scientific Publications

Search by Keyword(s)
Found 6 results

Filters: Author is Smith, RD  [Clear All Filters]

Search Results

  • Showing 1-6 of 6 Results
2016
Reproducibility of Differential Proteomic Technologies in CPTAC Fractionated Xenografts.Tabb, DL, Wang X., Carr SA, Clauser KR, Mertins P., Chambers MC, Holman JD, Wang J., Zhang B., Zimmerman LJ, Chen X., Gunawardena HP, Davies SR, Ellis MJ, Li S., Townsend RR, Boja ES, Ketchum KA, Kinsinger CR, Mesri M., et al. Journal of proteome research, 2016/03/04, Volume 15, Issue 3, p.691-706, (2016) Read More / View Supplemental Materials
Abstract
An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer.Ruggles, KV, Tang Z., Wang X., Grover H., Askenazi M., Teubl J., Cao S., McLellan MD, Clauser KR, Tabb DL, Mertins P., Slebos R., Erdmann-Gilmore P., Li S., Gunawardena HP, Xie L., Liu T., Zhou JY, Sun S., Hoadley KA, et al. Molecular & cellular proteomics : MCP, 2016/03/01, Volume 15, Issue 3, p.1060-71, (2016) Read More / View Supplemental Materials
Abstract
Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based Assays.Hoofnagle, AN, Whiteaker JR, Carr SA, Kuhn E., Liu T., Massoni SA, Thomas SN, Townsend RR, Zimmerman LJ, Boja E., Chen J., Crimmins DL, Davies SR, Gao Y., Hiltke TR, Ketchum KA, Kinsinger CR, Mesri M., Meyer MR, Qian WJ, et al. Clinical chemistry, 2016/01/01, Volume 62, Issue 1, p.48-69, (2016) Read More / View Supplemental Materials
Abstract
Using the CPTAC Assay Portal to Identify and Implement Highly Characterized Targeted Proteomics Assays.Whiteaker, JR, Halusa GN, Hoofnagle AN, Sharma V., Maclean B., Yan P., Wrobel JA, Kennedy J., Mani D. R., Zimmerman LJ, Meyer MR, Mesri M., Boja E., Carr SA, Chan DW, Chen X., Chen J., Davies SR, Ellis MJ, Fenyö D., et al. Methods in molecular biology (Clifton, N.J.), 2016/01/01, Volume 1410, p.223-36, (2016) Read More / View Supplemental Materials
Abstract
2015
Preserved DNA Damage Checkpoint Pathway Protects against Complications in Long-Standing Type 1 Diabetes.Bhatt, S., Gupta MK, Khamaisi M., Martinez R., Gritsenko MA, Wagner BK, Guye P., Busskamp V., Shirakawa J., Wu G., Liew CW, Clauss TR, Valdez I., El Ouaamari A., Dirice E., Takatani T., Keenan HA, Smith RD, Church G., Weiss R., et al. Cell metabolism, 2015/08/04, Volume 22, Issue 2, p.239-52, (2015) Read More / View Supplemental Materials
Abstract
2013
Connecting Genomic Alterations to Cancer Biology with Proteomics: The NCI Clinical Proteomic Tumor Analysis Consortium.Ellis, MJ, Gillette M., Carr SA, Paulovich AG, Smith RD, Rodland KK, Townsend RR, Kinsinger C., Mesri M., Rodriguez H., Liebler DC, and Clinical Proteomic Tumor Analysis Consortium(CPTAC) Cancer discovery, 2013/10/01, Volume 3, Issue 10, p.1108-12, (2013) Read More / View Supplemental Materials
Abstract
  • Showing 1-6 of 6 Results